Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis
Table 2
Clinical and laboratory characteristics of TBM patients.
Characteristic
Clinical manifestations
Fever
5 (50)
Meningeal signs
7 (70)
Focal deficit
6 (60)
Motor
5 (50)
Sensitive
3 (30)
Cognitive decline
3 (30)
Duration of symptoms (days)
44 (31–68)
GCS on admission, median (range)
14 (7–15)
BMRC stage, median (range)
1 (0–3)
History of PTB
2 (20)
Abnormal chest X-ray
4 (40)
CSF analysis
Leukocytes (cells/mm3)
256.5 (30.75–614.5)
Neutrophils (%)
4 (2.2–7.0)
Lymphocytes (%)
95.5 (51–99)
Glucose (mg/dL)
40 (24–44)
Proteins (mg/dL)
100 (66–198)
ADA (U/L)
11 (2.2–17.7)
Positive culture
2 (20)
Brain MRI
Vasculitis
4 (40)
Hydrocephalus
2 (20)
Basal meningeal enhancement
6 (60)
Data are displayed as median (IQR) or (%). ADA: adenosine deaminase; BMRC: British Medical Research Council; CSF: cerebrospinal fluid; CT: computed tomography; GCS: Glasgow Coma Scale; MRI: magnetic resonance imaging; PTB: pulmonary tuberculosis; TBM: tuberculous meningitis.
